Trials / Completed
CompletedNCT01256606
Prenatal Test for Fetal Aneuploidy Detection
Investigational Study of a Prenatal Diagnostic Test for Fetal Aneuploidy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,000 (actual)
- Sponsor
- Roche Sequencing Solutions · Industry
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to develop and evaluate a blood test for pregnant women for detection of fetal aneuploidy.
Conditions
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2010-12-08
- Last updated
- 2013-01-10
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01256606. Inclusion in this directory is not an endorsement.